Back to search

Article

Anti-IL-5 and anti-IL-5 receptor therapy significantly improves quality of life and FEV1 values in patients with severe asthma

2025-05-16

Abstract excerpt

<title>Abstract</title> <p>Asthma is a chronic inflammatory disease of the airways triggered by exogenous antigens. Among its variants, it is crucial to differentiate between severe asthma and asthma, which is difficult to control. Severe asthma is characterized by a lack of response to high doses of inhaled corticosteroids and long-acting beta-2 agonists, whereas difficult-to-control asthma is associated with po...

Topics

Open a Topic to create a Post that cites this publication.

Identifiers and source

Literature Corpus work
02eceb31-6bb8-5e6f-a476-dba744b7cdf7
DOI
10.21203/rs.3.rs-6543940/v1
Open publication

Related research

Semantic proximity does not establish scientific evidence.

Click a neighbor to travelStep 1 · 12 closest
Interactive article relationship graphSelect a related publication card to move it into the centre and load its closest explainable connections. Solid lines are source-backed structured connections. Dashed lines are semantic discovery signals and are not scientific evidence.
Anti-IL-5 and anti-IL-5 receptor therapy significantly improves quality of life and FEV1 values in patients with severe asthmaDOI 10.21203/rs.3.rs-6543940/v1
Anti-interleukin-5 therapy in severe asthma.Semantic proximity
Comparative effectiveness of Anti-IL5 and Anti-IgE biologic classes in severe asthma patients eligible for bothSemantic proximity
What goes up must come down: biomarkers and novel biologicals in severe asthma.Semantic proximity
Reslizumab in the treatment of severe eosinophilic asthma: an update.Semantic proximity
Safety of humanized monoclonal antibodies against IL-5 in asthma: focus on reslizumab.Semantic proximity
IL-5 and IL-5 receptor in asthmaSemantic proximity
IL-5 blockade restores the bronchial epithelium and attenuates airway remodelling in severe asthmaSemantic proximity
Effectiveness of mepolizumab in a real-life cohort of patients with severe refractory eosinophilic asthma and multiple comorbiditiesSemantic proximity
IL-5 and IL-5 receptor expression on human eosinophils in relation to eosinophil activation.Semantic proximity
Benralizumab for the add-on maintenance treatment of patients with severe asthma aged 12 years and older with an eosinophilic phenotype.Semantic proximity
¿p#1 Multidomain Clinical and Biological Remission with Tezepelumab in Severe Asthma: A 12-Month Multicentre Real-World StudySemantic proximity
Different expression levels of interleukin-35 in asthma phenotypes.Semantic proximity
Select a neighboring publication to make it the new centre.